Patents by Inventor Daria Narmoneva

Daria Narmoneva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210106819
    Abstract: A method of treating cancer is disclosed.
    Type: Application
    Filed: October 15, 2020
    Publication date: April 15, 2021
    Applicant: University of Cincinnati
    Inventors: Xiaoyang Qi, Ahmet Kaynak, Daria Narmoneva, Andrei Kogan
  • Patent number: 10188858
    Abstract: Methods and systems for treating a tissue with a high frequency electric field to activate MAPK/ERK pathways, induce angiogenesis, induce angionenic factos such as NO and VEGF, or promote wound healing. Aspects of the invention are directed to methods of treating chronic wounds such as diabetic ulcers and hypoxia induced wounds. Aspects utilize high frequency electric field having a frequency in the GHz range, and preferably between about 1 GHz and about 10 GHz.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: January 29, 2019
    Assignee: University Of Cincinnati
    Inventors: Daria Narmoneva, Andrei Kogan, Abdul Sheikh, Toloo Taghian
  • Publication number: 20150080784
    Abstract: Methods and systems for treating a tissue with a high frequency electric field to activate MAPK/ERK pathways, induce angiogenesis, induce angionenic factos such as NO and VEGF, or promote wound healing. Aspects of the invention are directed to methods of treating chronic wounds such as diabetic ulcers and hypoxia induced wounds. Aspects utilize high frequency electric field having a frequency in the GHz range, and preferably between about 1 GHz and about 10 GHz.
    Type: Application
    Filed: September 18, 2014
    Publication date: March 19, 2015
    Inventors: Daria Narmoneva, Andrei Kogan, Abdul Sheikh, Toloo Taghian
  • Publication number: 20040242469
    Abstract: The invention provides compositions comprising self-assembling peptide hydrogels and cardiovascular system cells, particularly endothelial cells, cultured in or on the gels. According to certain embodiments of the invention the endothelial cells form capillary-like structures. The endothelial cell-gel matrix serves as a pre-vascularized scaffold that may be used to culture additional cell types. Formation of mature blood vessels in or on the scaffold involves addition of smooth muscle cells and/or fibroblasts. Compositions of the invention may be used for cell culture and for administration to a subject to treat a variety of conditions including, but not limited to, myocardial dysfunction or damage.
    Type: Application
    Filed: May 7, 2003
    Publication date: December 2, 2004
    Inventors: Richard T. Lee, Roger D. Kamm, Daria Narmoneva, Shuguang Zhang